SCHEMBL12428462

SCHEMBL12428462

CCCCCCCCN1CCCc2cc(/C=c3/c(=C4\C(=O)N(c5ccccc5)N=C4C(=O)O)c(C)nn3-c3ccccc3)ccc21

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 10/20 0.38
ALDH1A1 P00352 9/20 0.38
MEN1 O00255 9/20 0.38
MAPT P10636 9/20 0.38
HPGD P15428 7/20 0.38
KDM4E B2RXH2 6/20 0.38
POLB P06746 4/20 0.38
RECQL P46063 4/20 0.38
TDP1 Q9NUW8 2/20 0.38
SMN1; SMN2 Q16637 3/20 0.37
HTT P42858 2/20 0.37
HKDC1 Q2TB90 1/20 0.37
APOBEC3A P31941 1/20 0.35
APOBEC3G Q9HC16 1/20 0.35
L3MBTL1 Q9Y468 5/20 0.35
LMNA P02545 5/20 0.35
CRHBP P24387 1/20 0.35
CRHR2 Q13324 1/20 0.35
BLM P54132 2/20 0.34
MCL1 Q07820 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12428460 0.94 KMT2A (0.39) KMT2AALDH1A1MEN1MAPTHPGD
SCHEMBL12428458 0.88 KMT2A (0.39) KMT2AALDH1A1MEN1MAPTHPGD
SCHEMBL12428474 0.85 KMT2A (0.37) KMT2AALDH1A1MEN1MAPTHPGD
SCHEMBL12428485 0.79 KMT2A (0.42) KMT2AALDH1A1MEN1MAPTHPGD
SCHEMBL12428450 0.78 KMT2A (0.39) KMT2AALDH1A1MEN1MAPTHPGD
SCHEMBL12428440 0.77 MEN1 (0.37) KMT2AALDH1A1MEN1MAPTKDM4E
SCHEMBL12428330 0.77 KMT2A (0.39) KMT2AALDH1A1MEN1MAPTHPGD
SCHEMBL12428311 0.76 APOBEC3A (0.52) KMT2AALDH1A1MEN1MAPTHPGD
SCHEMBL13866489 0.75 MEN1 (0.35) KMT2AALDH1A1MEN1MAPTHPGD
SCHEMBL12428243 0.74 PRF1 (0.37) KMT2AALDH1A1MEN1MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7977570-B2 Dye-sensitized photoelectric conversion device NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2011-07-12 US disclosed
US-20090084441-A1 Dye-sensitized photoelectric conversion device NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2009-04-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090084441-A1 Dye-sensitized photoelectric conversion device CRY1, H1-5, H1-0 KMT2A 105/4885ALDH1A1 235/4885MEN1 251/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.